Skip to main content
Equibles

Invesco Ltd.

Position in BBIO — BridgeBio Pharma, Inc.

CIK 914208 Atlanta, GA
Back to BBIO Full portfolio

Position in BBIO

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$275,645,559
-$65,416,803 QoQ
Shares Held
3,700,934
-19.4% QoQ
Ownership
1.89%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#13
of 472 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority Sole 0% Shared 98% None 2%

Common Shares in BBIO Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Invesco Ltd. holds $14,420,023,301 across 296 Biotechnology names. BBIO ranks #12 (1.9% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 8,043,052 $3,995,225,212
2 REGN
Regeneron Pharmaceuticals, Inc.
 3,940,665 $2,457,162,245
3 ALNY
Alnylam Pharmaceuticals, Inc.
 3,754,318 $1,130,162,341
4 INCY
Incyte Corp
 4,080,461 $462,561,050
5 ARGX
Argenx SE
 443,990 $411,920,598
6 AXSM
Axsome Therapeutics, Inc.
 1,671,684 $409,178,086
7 MRNA
Moderna, Inc.
 5,780,299 $404,794,337
8 LGND
Ligand Pharmaceuticals Inc
 1,201,644 $379,827,645

All Filings in BBIO

Export CSV
25 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $275,645,559 3,700,934
2026-03-31 $341,062,362 4,592,814
2025-12-31 $369,546,512 4,831,305
2025-09-30 $204,054,441 3,928,657
2025-06-30 $120,949,984 2,801,065
2025-03-31 $76,267,051 2,206,163
2024-12-31 $24,507,402 893,127
2024-09-30 $21,830,852 857,457
2024-06-30 $27,577,276 1,088,720
2024-03-31 $30,877,481 998,625
2023-12-31 $51,372,276 1,272,536
2023-09-30 $30,593,232 1,160,153
2023-06-30 $11,772,865 684,469
2023-03-31 $883,846 53,308
2022-12-31 $324,816 42,627
2022-09-30 $3,169,685 318,882
2022-06-30 $392,336 43,209
2022-03-31 $448,527 44,190
2021-12-31 $797,953 47,839
2021-09-30 $2,477,829 52,866
2021-06-30 $2,844,331 46,659
2021-03-31 $1,507,597 24,474
2020-12-31 $2,597,789 36,532
2020-09-30 $221,405 5,901
2020-03-31 $283,968 9,792